Filed 2.7y ago· Oct 10, 2023
32 days to disclose
Lois Frankel
DHouseFlorida-22
↓sold
AbbVie
ABBV
$1K-$15K
+12.5% vs S&P 500
Trade dateSep 8, 2023
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.




















| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Oct 10, 2023 2.7y ago | ![]() Lois Frankel DHouseFlorida-22 | ↓sold | AbbVie ABBV | Sep 8, 2023 32 days to disclose | Flat·+0.0% +12.5% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2023 2.7y ago | ![]() Lois Frankel DHouseFlorida-22 | ↓sold | Pfizer PFE | Sep 8, 2023 32 days to disclose | Flat·+0.0% +12.5% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2023 2.7y ago | ![]() Lois Frankel DHouseFlorida-22 | ↓sold | Merck MRK Stock | Sep 8, 2023 32 days to disclose | Flat·+0.0% +12.5% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2023 2.7y ago | ![]() Lois Frankel DHouseFlorida-22 | ↓sold | AbbVie ABBV | Sep 8, 2023 32 days to disclose | Flat·+0.0% +12.5% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2023 2.7y ago | ![]() Lois Frankel DHouseFlorida-22 | ↓sold | Johnson & Johnson JNJ | Sep 6, 2023 34 days to disclose | Flat·+0.0% +13.0% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2023 2.7y ago | ![]() Lois Frankel DHouseFlorida-22 | ↓sold | Merck MRK Stock | Sep 6, 2023 34 days to disclose | Flat·+0.0% +13.0% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2023 2.7y ago | ![]() Lois Frankel DHouseFlorida-22 | ↑bought | AbbVie ABBV | Aug 30, 2023 41 days to disclose | Good buy·+$3.8K+47.4% +37.3% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 26, 2023 2.8y ago | ![]() Lois Frankel DHouseFlorida-22 | ↑bought | Johnson & Johnson JNJ | Aug 10, 2023 16 days to disclose | Good buy·+$2.7K+34.3% +24.2% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 26, 2023 2.8y ago | ![]() Lois Frankel DHouseFlorida-22 | ↓sold | Merck MRK Stock | Aug 2, 2023 24 days to disclose | Flat·+0.0% +11.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 28, 2023 2.9y ago | ![]() Lois Frankel DHouseFlorida-22 | ↑bought | Pfizer PFE | Jul 12, 2023 16 days to disclose | Bad buy·−$2.1K-26.3% −40.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 28, 2023 2.9y ago | ![]() Lois Frankel DHouseFlorida-22 | ↓sold | Merck MRK Stock | Jun 28, 2023 30 days to disclose | Flat·+0.0% +13.8% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 13, 2023 3.2y ago | ![]() Lois Frankel DHouseFlorida-22 | ↓sold | Pfizer PFE | Feb 20, 2023 21 days to disclose | Flat·+0.0% +14.0% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 13, 2023 3.2y ago | ![]() Lois Frankel DHouseFlorida-22 | ↑bought | Johnson & Johnson JNJ | Feb 17, 2023 24 days to disclose | Good buy·+$3.7K+46.4% +33.9% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 18, 2022 3.5y ago | ![]() Lois Frankel DHouseFlorida-22 | ↑bought | Pfizer PFE | Nov 9, 2022 9 days to disclose | Bad buy·−$3.5K-43.2% −56.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 16, 2022 4.0y ago | ![]() Lois Frankel DHouseFlorida-22 | ↓sold | Merck MRK Stock | Jun 1, 2022 15 days to disclose | Flat·+0.0% +13.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 9, 2022 4.0y ago | ![]() Lois Frankel DHouseFlorida-22 | ↑bought | Johnson & Johnson JNJ | May 11, 2022 29 days to disclose | Good buy·+$2.5K+31.3% +13.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 9, 2022 4.0y ago | ![]() Lois Frankel DHouseFlorida-22 | ↓sold | Johnson & Johnson JNJ | Apr 25, 2022 45 days to disclose | Flat·+0.0% +10.4% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 6, 2022 4.2y ago | ![]() Lois Frankel DHouseFlorida-22 | ↓sold | Pfizer PFE | Mar 8, 2022 29 days to disclose | Flat·+0.0% +16.4% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 27, 2022 4.3y ago | ![]() Lois Frankel DHouseFlorida-22 | ↑bought | Pfizer PFE | Feb 2, 2022 25 days to disclose | Bad buy·−$4.1K-50.7% −62.1% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 16, 2022 4.4y ago | ![]() Lois Frankel DHouseFlorida-22 | ↑bought | Merck MRK Stock | Dec 3, 2021 44 days to disclose | Good buy·+$4.4K+54.8% +40.9% vs S&P 500 | $1K-$15K midpoint $8K |